IFNAR1 and liver disorder: Finally, when IFN-I signaling was blocked with an IFNAR1 mAb in HIV/cART mice (28, 41), it efficiently prevented the development of liver diseases, including reduced pathogenic macrophages and resolved fibrosis in the liver (Figure 6).